Mass spectrometry is already a powerful tool for determining what kind and how many molecules are present in a given sample.

The team, from biopharmaceutical company Regeneron, hopes their work will help researchers better understand protein-protein interactions during preclinical development of a drug. “Essentially, we ...

Refeyn, developer of pioneering mass photometry technology, announces the launch of MyMass™ mass photometer (MyMassMP), a compact instrument designed to answer a critical research question: Is the ...

Proteins, one of the smallest building blocks of life on Earth, hold promise for answering some of biology's biggest ...